IBDEI1IB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25180,0)
 ;;=D86.9^^124^1241^28
 ;;^UTILITY(U,$J,358.3,25180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25180,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,25180,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,25180,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,25181,0)
 ;;=E88.01^^124^1241^6
 ;;^UTILITY(U,$J,358.3,25181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25181,1,3,0)
 ;;=3^Alpha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,25181,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,25181,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,25182,0)
 ;;=J18.9^^124^1241^21
 ;;^UTILITY(U,$J,358.3,25182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25182,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,25182,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,25182,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,25183,0)
 ;;=J40.^^124^1241^10
 ;;^UTILITY(U,$J,358.3,25183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25183,1,3,0)
 ;;=3^Bronchitis
 ;;^UTILITY(U,$J,358.3,25183,1,4,0)
 ;;=4^J40.
 ;;^UTILITY(U,$J,358.3,25183,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,25184,0)
 ;;=J43.9^^124^1241^17
 ;;^UTILITY(U,$J,358.3,25184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25184,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,25184,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,25184,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,25185,0)
 ;;=J45.909^^124^1241^7
 ;;^UTILITY(U,$J,358.3,25185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25185,1,3,0)
 ;;=3^Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,25185,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,25185,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,25186,0)
 ;;=J47.9^^124^1241^9
 ;;^UTILITY(U,$J,358.3,25186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25186,1,3,0)
 ;;=3^Bronchiectasis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,25186,1,4,0)
 ;;=4^J47.9
 ;;^UTILITY(U,$J,358.3,25186,2)
 ;;=^5008260
 ;;^UTILITY(U,$J,358.3,25187,0)
 ;;=J44.9^^124^1241^11
 ;;^UTILITY(U,$J,358.3,25187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25187,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,25187,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,25187,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,25188,0)
 ;;=R09.1^^124^1241^20
 ;;^UTILITY(U,$J,358.3,25188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25188,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,25188,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,25188,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,25189,0)
 ;;=J90.^^124^1241^19
 ;;^UTILITY(U,$J,358.3,25189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25189,1,3,0)
 ;;=3^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,25189,1,4,0)
 ;;=4^J90.
 ;;^UTILITY(U,$J,358.3,25189,2)
 ;;=^5008310
 ;;^UTILITY(U,$J,358.3,25190,0)
 ;;=J95.811^^124^1241^22
 ;;^UTILITY(U,$J,358.3,25190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25190,1,3,0)
 ;;=3^Pneumothorax,Postprocedural
 ;;^UTILITY(U,$J,358.3,25190,1,4,0)
 ;;=4^J95.811
 ;;^UTILITY(U,$J,358.3,25190,2)
 ;;=^5008336
 ;;^UTILITY(U,$J,358.3,25191,0)
 ;;=J84.10^^124^1241^25
 ;;^UTILITY(U,$J,358.3,25191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25191,1,3,0)
 ;;=3^Pulmonary Fibrosis,Unspec
 ;;^UTILITY(U,$J,358.3,25191,1,4,0)
 ;;=4^J84.10
 ;;^UTILITY(U,$J,358.3,25191,2)
 ;;=^5008300
 ;;^UTILITY(U,$J,358.3,25192,0)
 ;;=J84.89^^124^1241^18
 ;;^UTILITY(U,$J,358.3,25192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25192,1,3,0)
 ;;=3^Interstitial Pulmonary Diseases
 ;;^UTILITY(U,$J,358.3,25192,1,4,0)
 ;;=4^J84.89
 ;;^UTILITY(U,$J,358.3,25192,2)
 ;;=^5008303
 ;;^UTILITY(U,$J,358.3,25193,0)
 ;;=J98.11^^124^1241^8
 ;;^UTILITY(U,$J,358.3,25193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25193,1,3,0)
 ;;=3^Atelectasis
